Evidence map›Paper›PMID 40220117›Full record

ArticleInternational journal of hematology2025

Use of activated partial thrombin time and prothrombin time for quality assessment of fresh frozen plasma.

Yao Layibo, Essohana Padaro, Hèzouwè Magnang, Magnime Badassan, Irenée M D Kuéviakoé, Koffi Mawussi, Lochina Fétéké

Abstract read
PubMed Publisher
In one paragraph

Article in International journal of hematology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yao LayiboNational Institute of Hygiene, Lome, Togo. mylayibo@yahoo.fr.ORCID http://orcid.org/0009-0003-5129-8329
Essohana PadaroDepartment of Health Sciences, University of Lome, Lome, Togo.
Hèzouwè MagnangDepartment of Health Sciences, University of Lome, Lome, Togo.
Magnime BadassanNational Blood Transfusion Center, Lome, Togo.
Irenée M D KuéviakoéDepartment of Health Sciences, University of Lome, Lome, Togo.
Koffi MawussiDepartment of Health Sciences, University of Kara, Kara, Togo.
Lochina FétékéNational Blood Transfusion Center, Lome, Togo.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this study was to evaluate the usefulness of activated partial thromboplastin time (APTT) and prothrombin time (PT) for determining the quality of fresh frozen plasma (FFP) units in low-income countries. Quality control was conducted for 66 randomly selected FFP units after 3 months of freezing at - 20 °C. The average volume of the FFP units was 177.8 ± 17.3 mL, with average concentrations of 79.9 ± 40.2 IU/dL for factor VIII, 83.4 ± 29.3 IU/dL for factor IX, and 2.3 ± 0.7 g/L for fibrinogen. Fifty-six percent of the FFP units had a factor VIII level greater than or equal to 70 IU/dL. Unlike PT, the PT ratio, and the international normalized ratio, both APTT and the APTT ratio provided useful information regarding factor VIII level compliance, with areas under the curve of 71% and 73%, respectively. The optimal cutoff values for FFP unit compliance assessment were 40 s for APTT and 1.23 for the APTT ratio. Accuracy rates were 65% and 70%, with Cohen's kappa coefficients of 0.31 and 0.40 for the APTT and APTT ratios, respectively. APTT outperformed PT, and showed fair to moderate agreement with factor VIII level compliance in FFP units.

Indexed as

PlasmaProthrombin TimeFactor IXFactor VIIIHumansPartial Thromboplastin TimeQuality ControlFactor IXFactor VIIIActivated partial thromboplastin timeFactor VIIIFresh frozen plasmaProthrombin timeQuality control

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.